Impact of CALR and JAK2 V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.

Zehra Narlı Özdemir Yıldız İpek Pusem Patir Gözde Ermiş Rafiye Ciftciler Deniz Özmen Mehmet Baysal Vildan Gursoy Esra Yıldızhan Serkan Güven Tarık Ercan Tayfun Elibol Sinan Mersin Eylem Genç Eren Arslan Davulcu Volkan KarakusNergiz ErkutGürsel Güneş Reyhan Diz Küçükkaya Ahmet Emre Eskazan

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2024)

V617F was strongly associated with thrombosis and worse TFS. Hydroxyurea was the most preferred cytoreductive agent for patients with high thrombosis risk.

Keyphrases

end stage renal disease
pulmonary embolism
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
type diabetes
cross sectional
clinical trial
skeletal muscle
insulin resistance
patient reported